School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China; College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China.
School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China.
Carbohydr Polym. 2022 Sep 1;291:119564. doi: 10.1016/j.carbpol.2022.119564. Epub 2022 May 4.
Human milk oligosaccharides (HMOs) are complex glycans that are the third largest solid component in human milk. It has attracted great interest in recent years due to their critical role in boosting infant health. These oligosaccharides play an important role in a variety of physiological processes, such as shaping the infant gut microbiome, preventing pathogenic infections and promoting the development of immune system. However, limited availability of HMOs hampered their use in food and medical areas. Moreover, most of the HMOs are unique to human milk and difficult to isolate. The strategies, chemical synthesis, whole-cell fermentation, and purification from human milk, have their advantages and come with their own challenges. In this review, we examined the remarkable progress that has been made in the enzymatic and chemoenzymatic synthesis of HMOs, and discussed the challenges and opportunities in large-scale synthesis of HMOs.
人乳寡糖(HMOs)是复杂的糖缀合物,是母乳中第三大固体成分。由于其在促进婴儿健康方面的关键作用,近年来引起了极大的关注。这些寡糖在多种生理过程中发挥着重要作用,例如塑造婴儿肠道微生物组、预防病原性感染和促进免疫系统发育。然而,HMOs 的有限可用性限制了它们在食品和医疗领域的应用。此外,大多数 HMOs 是母乳所特有的,难以分离。从母乳中提取 HMOs 的策略、化学合成、全细胞发酵和纯化都有其优势,也有各自的挑战。在这篇综述中,我们检查了在 HMOs 的酶法和化学酶法合成方面取得的显著进展,并讨论了 HMOs 大规模合成所面临的挑战和机遇。